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Achromatopsia (ACHM) is a congenital cone photoreceptor disorder with a presumed stationary course. The estimated prevalence is 1:30.000. ACHM is characterized by low visual acuity, photophobia, nystagmus, severe color vision defects, and a presumably normal macular appearance. 1 The inheritance is autosomal recessive, and the known responsible genes are CNGA3, CNGB3, GNAT2, and PDE6C. [2] [3] [4] [5] Together, these genes explain the majority (>90%) of all ACHM cases. Although it is known that these genes code for essential proteins in the cone phototransduction cascade, repair of the gene defects is not feasible as yet.
A promising therapy which is currently under investigation is cone-targeted gene therapy. The first results of animal studies showed that CNGB3, CNGA3 or GNAT2 knockout mice and dogs responded well to adeno-associated virus gene therapy. In these rescued animals, cone ERG amplitudes recovered to nearly normal levels. 6, 7 The next step in this development will be gene therapy in humans with cone dysfunction. For that purpose, it is crucial to know whether the non-functional cones are present in the macula and still viable. 8 The aim of this study was to investigate the presence of cone cells as a function of age in ACHM. We compared foveal morphology in 40 ACHM patients of various ages with 55 healthy age-matched controls using a new spectralis domain optical coherence tomogram (SD-OCT; Heidelberg Spectralis). This device has a high reproducibility 9 , and a better resolution than the conventional OCT, and its images correlate well with histopathology in vivo. 10 Heidelberg Eye Explorer version 1.61 software was used for all measurements. We performed a single section action (one B-scan, 30 degrees, 768 pixels) to obtain a longitudinal section across the center of the macula, and we performed a volume scan (19 Bscans, 20x15 degrees, 512 pixels, 12 frames per B-scan) to ensure capturing the center of the fovea. When the nystagmus in ACHM patients was so severe that it impaired the tracking system of the OCT, settings for resolution, speed, the number of B-scans and the number of frames per B-scan were adjusted.
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Methods
Study
Retinal thickness measurements in the fovea included the following structures: outer nuclear layer (ONL), inner and outer segments of the cone cells, and retinal pigment epithelium (RPE). Measurements were determined per ETDRS area 12 using the automated measurements from the software. We calculated retinal thickness in the fovea manually by searching the thinnest point in the fovea with the Heidelberg Eye Explorers tool. We placed 3,)"'&+',+,('.)"$+'-$+F,("#2%)$&+,1+'-$+1,>$2.+3)'A+2"#+'-$"+(&$#+'-$+&E&'$90&+9$2&(%$9$"'+ tool to calculate depth and width of the fovea. In subjects with foveal hypoplasia or a t-test for continuous variables, and one-way ANOVA for categorical variables. First, we calculated between-eye correlations for the OCT measurements. Correlations between continuous variables, e.g. foveal thickness and disease status (ACHM, control) were @2.@(.2'$#+B)'-+2+F)>2%)2'$+Q$2%&,"0&+@,%%$.2'),"+'$&'R+@,%%$.2'),ns between categorical variables, e.g. macular appearance, were analyzed with Spearman correlation analysis.
Differences in presence of cone and RPE cell disruption were analyzed using the Chi-square test. Within the cases, we further examined whether age, visual acuity and/or macular appearance influenced foveal thickness with linear regression analysis.
Results
Clinical features
Baseline characteristics of the study population are presented in Table 1 . Figure 1A/B ). This feature was present in 28/40 (70%) of all ACHM, and showed a strong association with age. In the age group 0-10, only one (1/7; 14%) child had this feature;
while in the oldest age-group all patients (7/7, 100%) showed this characteristic (Figure 2) .
Fundus photographs of patients with only loss of IS and OS (n=2) showed no abnormalities. 
Foveal hypoplasia
In the fovea of 80% (24/30) of ACHM patients, we noticed multiple ganglion cell layers.
These extra layers indicate a lack of formation of the foveal pit, i.e., foveal hypoplasia. This phenomenon was always present bilaterally. It occurred in all age-groups of patients, and in one 51-year old control person with a Snellen visual acuity of 1.25 in both eyes, no color vision defects, and a normal macular appearance. Those with foveal hypoplasia had a less steep foveal slope than those with a normal fovea (92 µm versus 133 µm, P=0.02), but had no differences in foveal width (2004 µm versus 2126 µm, P=0.20) (Figure 3 ). Fundus photographs showed absent foveal reflexes only in 50% of patients with hypoplasia, and revealed normal macular appearance in the remaining half.
Discussion
Our study provides evidence that cone cells die progressively in ACHM. The first signs of decay were loss of IS and OS with a disruption of the ciliary layer on OCT, followed by appearance of an evolving bubble with cell loss in the cone photoreceptor layer. The endstage was characterized by atrophy of the RPE. This cascade of events had its onset predominantly in the second decade, and showed a strong association with age thereafter.
Before any signs of decay were visible, the foveal and parafoveal regions were already significantly thinner in ACHM patients than in age-matched controls. With the appearance of cone cell degeneration, thinning of the retina became more pronounced.
A strength of this study was the use of the recently developed SD-OCT. The resolution of this device is 50 times higher than the conventional Stratus OCT, making it possible to distinguish the different retinal layers, and to analyze changes on a cellular level. 13 Moreover, the SD-OCT has settings which are adjustable for the individual patient, facilitating measurements in patients with congenital nystagmus and in young children. 9 A limitation of the study was the relatively small sample size and the cross-sectional character of the study. Only larger studies with longer follow-up can overcome this problem.
Nevertheless, to our knowledge, the current investigation is the largest imaging study in ACHM to date. The wide age-range in subjects who were otherwise homogeneous in genotype and disease-onset enables interpretation of the clinical course over time. Foveal hypoplasia was a frequent phenomenon in the ACHM patients of our study (24/30;80%). This has been reported in histology studies, but not yet confirmed in in vivo imaging studies. 15,20 Foveal hypoplasia is not specific for ACHM, but is also present in other congenital eye disorders such as ocular albinism and aniridia. 21, 22 In the healthy eye, foveal development takes place at 24-36 weeks of gestation by thinning of the ganglion cell layers and thickening of the ONL. The final relocation of the inner nuclear and ganglion cell layers to the periphery takes places at four months after birth, resulting in uncovered foveal cone nuclei thereafter. 23 Our ACHM patients with foveal hypoplasia appeared to have missed these early foveal developments; they showed no thickening of the ONL, persistent ganglion cell layers, and a significantly less steep foveal slope (Figure 3 ). Remarkably, one control person also had foveal hypoplasia with extra ganglion cell layers. The difference with the ACHM patients was that this person had a normal thickness of the ONL. We do not know the exact mechanism behind this abberant retinal development. However, the range in the measurements of the width (range 1665-2629 µm; SD: 257) and the slope of the fovea (range 91-173 µm; SD: 20) was large in our healthy controls, indicating that normal foveal development varies considerably among subjects with normal visual acuity. The diagnosis of foveal hypoplasia was by far more sensitive on OCT than on fundus photographs, suggesting that abberant foveal development may be more common than presumed. Half of the ACHM patients with foveal hypoplasia on OCT showed a normal macular appearance. In these patients, a minor slope was often present giving the impression of a normal foveal reflex ( Figure 3 ).
What do our results indicate for the application of future therapies? They imply that the foveal cones of ACHM patients, although reduced in number, are morphologically intact at birth. However, after the first decade, cone cell loss occurs progressively in a relatively short time period. Therefore, our results suggest that if gene therapy becomes available in the future, earlier application may be preferable to later application.
In conclusion, our study provides profound evidence that ACHM is not a stationary disease, but a disorder which shows progressive loss of cone photoreceptors. SD-OCT is a valuable, non-invasive tool to visualize the severity of the cone decay, and a helpful means to give insight in the cellular changes present in ACHM.
